U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 33

Tests names and labsConditionsGenes, analytes, and microbesMethods

ANG - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoNeuro Panel

Centogene AG - the Rare Disease Company
Germany
18861858
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel

Centogene AG - the Rare Disease Company
Germany
6466
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Hereditary Amyotrophic Lateral Sclerosis, Frontotemporal Dementia and Alzheimer Disease Panel 

Invitae
United States
7233
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel

PreventionGenetics, part of Exact Sciences
United States
4839
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic Lateral Sclerosis (ALS) Panel

PreventionGenetics, part of Exact Sciences
United States
3632
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic lateral sclerosis 9, 611895; ALS9 (Amyotrophic lateral sclerosis) (ANG gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis via the ANG Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic lateral sclerosis 9 (sequence analysis of ANG gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

Amyotrophic lateral sclerosis panel. 32-gene NGS panel.

Genologica Medica
Spain
6632
  • C Sequence analysis of the entire coding region

ANG - Gene sequencing

Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center, Location AMC
Netherlands
11
  • C Sequence analysis of the entire coding region

Frontotemporal dementia and/or Amyotrophic Lateral Sclerosis: Full gene sequencing panel

CEN4GEN Institute for Genomics and Molecular Diagnostics
Canada
3030
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis (NGS Panel and Copy Number Analysis)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
2530
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis , Panel Massive Sequencing (NGS) 12 Genes

Reference Laboratory Genetics
Spain
1212
  • C Sequence analysis of the entire coding region

AMYOTROPHIC LATERAL SCLEROSIS (ALS) (AUTOSOMAL DOMINANT)

Laboratorio de Genetica Clinica SL
Spain
1417
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amyotrophic Lateral Sclerosis

Asper Biogene Asper Biogene LLC
Estonia
2222
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis , Sequencing ANG Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Invitae Amyotrophic Lateral Sclerosis Panel

Invitae
United States
2921
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation

Athena Diagnostics
United States
2415
  • C Sequence analysis of the entire coding region

Amyotrophic Lateral Sclerosis Advanced Evaluation

Athena Diagnostics
United States
1917
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 33

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.